Kyowa Kirin Co.,Ltd. (4151)

Market cap
¥1.26T
P/E ratio
16.7x
Kyowa Kirin manufactures and sells prescription pharmaceuticals through integrated operations from drug development to sales, serving healthcare markets globally.
Period EndIncome before tax (Million JPY)YoY (%)
Dec 31, 202587,221+4.52%
Dec 31, 202483,453-14.18%
Dec 31, 202397,246+43.91%
Dec 31, 202267,572+12.53%
Dec 31, 202160,050+14.90%
Dec 31, 202052,263+17.47%
Dec 31, 201944,492-39.42%
Dec 31, 201873,438+31.49%
Dec 31, 201755,849+111.57%
Dec 31, 201626,397-32.67%
Dec 31, 201539,203+32.84%
Dec 31, 201429,511-40.38%
Dec 31, 201349,502+1.02%
Dec 31, 201249,001+4.81%
Dec 31, 201146,754
AI Chat